SCHEMBL6508816

SCHEMBL6508816

CCN(CC)N=Nc1ccc(CCc2ccc(N=NN(CC)CC)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.56
▸ P2RY6 Q15077 1/20 0.38
▸ NPC1 O15118 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ NOS3 P29474 3/20 0.33
▸ NOS1 P29475 3/20 0.33
▸ NOS2 P35228 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ CYP2C9 P11712 2/20 0.33
▸ CHRNA7 P36544 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PLAU P00749 1/20 0.31
▸ TAAR1 Q96RJ0 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ ESR1 P03372 1/20 0.31
▸ ESR2 Q92731 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517947 0.88 MAPT (0.56) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL6517951 0.88 MAPT (0.56) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL14366560 0.81 MAPT (0.58) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL1754834 0.79 MAPT (0.56) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL2107416 0.79 MAPT (0.56) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL2107414 0.79 MAPT (0.56) MAPTNPC1RAB9AALDH1A1POLB
SCHEMBL973245 0.78 MAPT (0.55) MAPTNPC1RAB9AALDH1A1NOS3
SCHEMBL3500948 0.78 MAPT (0.55) MAPTNPC1RAB9AALDH1A1NOS3
SCHEMBL973244 0.78 MAPT (0.55) MAPTNPC1RAB9AALDH1A1NOS3
SCHEMBL10048467 0.78 MAPT (0.58) MAPTNPC1RAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050101063-A1 Three-terminal field-controlled molecular devices TOUR JAMES M (US) 2005-05-12 — — US disclosed
WO-2005003125-A1 PROCESS FOR THE PREPARATION OF 4,4-DIMETHYL-6-ETHYNYLTHIOCHROMAN GLENMARK PHARMACEUTICALS LIMITED (US) 2005-01-13 — — WO disclosed
WO-2002035580-A2 THREE-TERMINAL FIELD-CONTROLLED MOLECULAR DEVICES MOLECULAR ELECTRONICS CORPORATION (US) 2002-05-02 — — WO disclosed
Send feedback